New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against […]
The Deutsche Apotheker Zeitung (DAZ) represents an independent pharmaceutical journal for science and practice. Appearing weekly, the publication is targeted […]
It used to be a reality that if one was diagnosed with cancer and lived in Connecticut or rural communities […]
TrialSite News is, above all, dedicated to transparency and access to clinical trials with an emphasis on clinical research sites […]
Lupus, an autoimmune disease where the body rejects its own cells, turns one’s immune system into its’ own enemy. With […]
Boston, the world’s biotech capital, became the location for one of biotech’s most important but not well-known legal battles. On […]
LifeSci NYC represents part of a $500 million commitment to growing New York City’s life science industry. The Flatiron District-based, […]
US News & World Report recently published its annual Best Hospitals Honor Roll 2019. TrialSite News includes the top 20 […]
Recently, TrialSite News summarized a story that merited a deeper review. The small, Chicago-based biotech venture Errant Gene Therapeutics, LLC […]
Tim Povtak of Asbestos.com reports that a recent study of mesothelioma patients over 80 has revealed the disturbing reality that nearly […]
